Tech Company Financing Transactions
Tribune Therapeutics Funding Round
On 3/26/2025, Tribune Therapeutics secured $40 million in investment from LifeArc, Healthcap Venture Capital and Industrifonden.
Transaction Overview
Company Name
Announced On
3/26/2025
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance a portfolio of therapies targeting central drivers of scar tissue formation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Engelbrektsplan 1
Stockholm, 114 34
Sweden
Stockholm, 114 34
Sweden
Phone
Undisclosed
Website
Email Address
Overview
Our mission is to treat fibrosis, regardless of the cause, tissue or diagnosis. At Tribune Therapeutics, we are developing novel medicines that efficiently target multiple drivers of fibrosis to stop this cycle of scar formation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Georg Beiske
Browse more venture capital transactions:
Prev: 3/26/2025: Jolly venture capital transaction
Next: 3/26/2025: Brisk Teaching venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. VC transactions on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs